Cooper Firms (NASDAQ:COO – Get Free Report) had its worth goal boosted by Wells Fargo & Firm from $110.00 to $115.00 in a report launched on Thursday, Benzinga stories. The brokerage at present has an “obese” score on the medical machine firm’s inventory. Wells Fargo & Firm‘s worth goal factors to a possible upside of 21.64% from the inventory’s present worth.
A number of different analysis corporations additionally lately commented on COO. Robert W. Baird boosted their goal worth on shares of Cooper Firms from $116.00 to $118.00 and gave the inventory an “outperform” score in a analysis report on Friday, Could thirty first. Jefferies Monetary Group upgraded Cooper Firms from a “maintain” score to a “purchase” score and upped their worth goal for the inventory from $107.00 to $115.00 in a report on Tuesday, July sixteenth. Needham & Firm LLC reaffirmed a “maintain” score on shares of Cooper Firms in a report on Friday, August twenty third. Lastly, Piper Sandler elevated their goal worth on shares of Cooper Firms from $115.00 to $120.00 and gave the corporate an “obese” score in a report on Thursday. 4 equities analysis analysts have rated the inventory with a maintain score and ten have issued a purchase score to the corporate. In response to MarketBeat, Cooper Firms presently has a mean score of “Reasonable Purchase” and a mean worth goal of $113.16.
Learn Our Newest Analysis Report on COO
Cooper Firms Inventory Efficiency
Shares of COO opened at $94.54 on Thursday. The inventory has a 50-day shifting common of $90.97 and a 200-day shifting common of $94.04. The corporate has a market cap of $18.82 billion, a PE ratio of 55.61, a P/E/G ratio of two.34 and a beta of 0.98. The corporate has a debt-to-equity ratio of 0.34, a present ratio of 1.95 and a fast ratio of 1.14. Cooper Firms has a one 12 months low of $75.93 and a one 12 months excessive of $104.07.
Cooper Firms (NASDAQ:COO – Get Free Report) final launched its quarterly earnings knowledge on Wednesday, August twenty eighth. The medical machine firm reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Firms had a return on fairness of 8.87% and a web margin of 9.11%. The agency had income of $1 billion in the course of the quarter, in comparison with the consensus estimate of $997.30 million. Throughout the identical quarter within the earlier 12 months, the corporate posted $0.84 earnings per share. The corporate’s quarterly income was up 7.8% on a year-over-year foundation. On common, equities analysis analysts predict that Cooper Firms will submit 3.57 EPS for the present fiscal 12 months.
Institutional Inflows and Outflows
Plenty of hedge funds have lately added to or diminished their stakes in COO. Benjamin F. Edwards & Firm Inc. lifted its stake in Cooper Firms by 248.6% within the 1st quarter. Benjamin F. Edwards & Firm Inc. now owns 244 shares of the medical machine firm’s inventory price $25,000 after buying an extra 174 shares within the final quarter. Innealta Capital LLC purchased a brand new place in Cooper Firms within the 2nd quarter price about $25,000. Covestor Ltd raised its holdings in shares of Cooper Firms by 305.9% within the 1st quarter. Covestor Ltd now owns 276 shares of the medical machine firm’s inventory valued at $28,000 after buying an extra 208 shares within the final quarter. Crewe Advisors LLC boosted its place in shares of Cooper Firms by 286.4% in the course of the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical machine firm’s inventory valued at $30,000 after buying an extra 252 shares over the last quarter. Lastly, International Retirement Companions LLC elevated its place in shares of Cooper Firms by 358.6% within the first quarter. International Retirement Companions LLC now owns 321 shares of the medical machine firm’s inventory price $33,000 after buying an extra 251 shares over the last quarter. Hedge funds and different institutional buyers personal 24.39% of the corporate’s inventory.
Cooper Firms Firm Profile
The Cooper Firms, Inc, along with its subsidiaries, develops, manufactures, and markets contact lens wearers. The corporate operates in two segments, CooperVision and CooperSurgical. The CooperVision section supplies spherical lense, together with lenses that right close to and farsightedness; and toric and multifocal lenses comprising lenses correcting imaginative and prescient challenges, comparable to astigmatism, presbyopia, and myopia within the Americas, Europe, Center East, Africa, and Asia Pacific.
Featured Articles
Obtain Information & Scores for Cooper Firms Each day – Enter your electronic mail handle beneath to obtain a concise every day abstract of the most recent information and analysts’ rankings for Cooper Firms and associated corporations with MarketBeat.com’s FREE every day electronic mail publication.
